{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:14:07Z","timestamp":1744200847415,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/12074-5"],"award-info":[{"award-number":["2019\/12074-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2021,10,30]]},"DOI":"10.1007\/s11060-021-03848-x","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T04:13:35Z","timestamp":1632716015000},"page":"13-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Molecular profiling of pediatric and adolescent ependymomas: identification of genetic variants using a next-generation sequencing panel"],"prefix":"10.1007","volume":"155","author":[{"given":"D\u00e9bora","family":"Cabral de Carvalho Corr\u00eaa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Tesser-Gamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indhira","family":"Dias Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasjla","family":"Saba da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Maria","family":"Capellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"de Seixas Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederico Adolfo","family":"Benevides Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia Alessandra","family":"Dastoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Cavalheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7808-3393","authenticated-orcid":false,"given":"Silvia Regina","family":"Caminada de Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"key":"3848_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro Oncol 21:v1\u2013v100. https:\/\/doi.org\/10.1093\/neuonc\/noz150","journal-title":"Neuro Oncol"},{"key":"3848_CR2","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s00381-021-05207-7","volume":"37","author":"ST J\u00fcnger","year":"2021","unstructured":"J\u00fcnger ST, Timmermann B, PietschT, (2021) Pediatric ependymoma: an overview of a complex disease. Childs Nerv Syst 37:2451\u20132463. https:\/\/doi.org\/10.1007\/s00381-021-05207-7","journal-title":"Childs Nerv Syst"},{"issue":"30","key":"3848_CR3","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.2217\/fon-2018-0502","volume":"14","author":"S Khatua","year":"2018","unstructured":"Khatua S, Mangum R, Bertrand KC, Zaky W, McCall D, Mack SC (2018) Pediatric ependymoma: current treatment and newer therapeutic insights. Future Oncol 14(30):3175\u20133186. https:\/\/doi.org\/10.2217\/fon-2018-0502","journal-title":"Future Oncol"},{"issue":"5","key":"3848_CR4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","volume":"27","author":"KW Pajtler","year":"2015","unstructured":"Pajtler KW, Witt H, Sill M et al (2015) Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27(5):728\u2013743. https:\/\/doi.org\/10.1016\/j.ccell.2015.04.002","journal-title":"Cancer Cell"},{"issue":"1","key":"3848_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-016-1643-0","volume":"133","author":"KW Pajtler","year":"2017","unstructured":"Pajtler KW, Mack SC, Ramaswamy V et al (2017) The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants. Acta Neuropathol 133(1):5\u201312. https:\/\/doi.org\/10.1007\/s00401-016-1643-0","journal-title":"Acta Neuropathol"},{"issue":"8","key":"3848_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"3848_CR7","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1158\/2159-8290.CD-20-1066","volume":"1066","author":"A Arabzade","year":"2021","unstructured":"Arabzade A, Zhao Y, Varadharajan S et al (2021) ZFTA-RELA dictates oncogenic transcriptional programs to drive aggressive supratentorial ependymoma. Cancer Discov 1066:2020. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1066","journal-title":"Cancer Discov"},{"issue":"6","key":"3848_CR8","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00401-020-02225-8","volume":"140","author":"JJ Zhu","year":"2020","unstructured":"Zhu JJ, Jillette N, Li XN, Cheng AW, Lau CC (2020) C11orf95-RELA reprograms 3D epigenome in supratentorial ependymoma. Acta Neuropathol 140(6):951\u2013960. https:\/\/doi.org\/10.1007\/s00401-020-02225-8","journal-title":"Acta Neuropathol"},{"key":"3848_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-021-05207-7","author":"ST J\u00fcnger","year":"2021","unstructured":"J\u00fcnger ST, Timmermann B, Pietsch T (2021) Pediatric ependymoma: an overview of a complex disease. Childs Nerv Syst. https:\/\/doi.org\/10.1007\/s00381-021-05207-7","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"3848_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ccr.2011.07.007","volume":"20","author":"H Witt","year":"2011","unstructured":"Witt H et al (2011) Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 20(2):143\u2013157. https:\/\/doi.org\/10.1016\/j.ccr.2011.07.007","journal-title":"Cancer Cell"},{"issue":"22","key":"3848_CR11","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.1158\/1078-0432.CCR-14-0833","volume":"20","author":"A Gajjar","year":"2014","unstructured":"Gajjar A, Pfister SM, Taylor MD, Gilbertson RJ (2014) Molecular insights into pediatric brain tumors have the potential to transform therapy. Clin Cancer Res 20(22):5630\u20135640. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0833","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3848_CR12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/neuonc\/now254","volume":"19","author":"CN Kline","year":"2017","unstructured":"Kline CN et al (2017) Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro Oncol 19(5):699\u2013709. https:\/\/doi.org\/10.1093\/neuonc\/now254","journal-title":"Neuro Oncol"},{"issue":"4","key":"3848_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/ht7040039","volume":"7","author":"AA Ahmed","year":"2018","unstructured":"Ahmed AA, Vundamati DS, Farooqi MS, Guest E (2018) Precision medicine in pediatric cancer: current applications and future prospects. High Throughput 7(4):39. https:\/\/doi.org\/10.3390\/ht7040039","journal-title":"High Throughput"},{"issue":"6","key":"3848_CR14","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jmoldx.2018.06.009","volume":"20","author":"MC Hiemenz","year":"2018","unstructured":"Hiemenz MC, Ostrow DG, Busse TM et al (2018) OncoKids: a comprehensive next-generation sequencing panel for pediatric malignancies. J Mol Diagn 20(6):765\u2013776. https:\/\/doi.org\/10.1016\/j.jmoldx.2018.06.009","journal-title":"J Mol Diagn"},{"issue":"12","key":"3848_CR15","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1097\/PAS.0000000000001342","volume":"43","author":"L Wang","year":"2019","unstructured":"Wang L, Liu L, Li H et al (2019) RELA fusion in supratentorial extraventricular ependymomas: a morphologic, immunohistochemical, and molecular study of 43 cases. Am J Surg Pathol 43(12):1674\u20131681. https:\/\/doi.org\/10.1097\/PAS.0000000000001342","journal-title":"Am J Surg Pathol"},{"issue":"7489","key":"3848_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature13108","volume":"506","author":"SC Mack","year":"2014","unstructured":"Mack SC, Witt H, Piro RM et al (2014) Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature 506(7489):445\u2013450. https:\/\/doi.org\/10.1038\/nature13108","journal-title":"Nature"},{"issue":"4","key":"3848_CR17","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3171\/jns.2002.97.4.0827","volume":"97","author":"ML van Veelen-Vincent","year":"2002","unstructured":"van Veelen-Vincent ML, Pierre-Kahn A, Kalifa C et al (2002) Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy. J Neurosurg 97(4):827\u2013835. https:\/\/doi.org\/10.3171\/jns.2002.97.4.0827","journal-title":"J Neurosurg"},{"issue":"5","key":"3848_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3892\/mco.2021.2250","volume":"14","author":"HJ Cho","year":"2021","unstructured":"Cho HJ, Park HY, Kim K et al (2021) Methylation and molecular profiles of ependymoma: influence of patient age and tumor anatomic location. Mol Clin Oncol 14(5):88. https:\/\/doi.org\/10.3892\/mco.2021.2250","journal-title":"Mol Clin Oncol"},{"issue":"3","key":"3848_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/bpa.12664","volume":"29","author":"M Pag\u00e8s","year":"2019","unstructured":"Pag\u00e8s M, Pajtler KW, Puget S et al (2019) Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging. Brain Pathol 29(3):325\u2013335. https:\/\/doi.org\/10.1111\/bpa.12664","journal-title":"Brain Pathol"},{"issue":"1","key":"3848_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40478-019-0793-4","volume":"7","author":"G Jungwirth","year":"2019","unstructured":"Jungwirth G et al (2019) Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT. Acta Neuropathol Commun 7(1):140. https:\/\/doi.org\/10.1186\/s40478-019-0793-4","journal-title":"Acta Neuropathol Commun"},{"key":"3848_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s40478-014-0167-x","volume":"2","author":"GM Shankar","year":"2014","unstructured":"Shankar GM et al (2014) Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta Neuropathol Commun 2:167. https:\/\/doi.org\/10.1186\/s40478-014-0167-x","journal-title":"Acta Neuropathol Commun"},{"key":"3848_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41467-018-08087-9","volume":"10","author":"S Bunda","year":"2019","unstructured":"Bunda S, Heir P, Metcalf J et al (2019) CIC protein instability contributes to tumorigenesis in glioblastoma. Nat Commun 10:661. https:\/\/doi.org\/10.1038\/s41467-018-08087-9","journal-title":"Nat Commun"},{"issue":"Pt6","key":"3848_CR23","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1242\/jcs.092965","volume":"125","author":"G Jim\u00e9nez","year":"2012","unstructured":"Jim\u00e9nez G, Shvartsman SY, Paroush Z (2012) The Capicua repressor\u2013a general sensor of RTK signaling in development and disease. J Cell Sci 125(Pt6):1383\u20131391. https:\/\/doi.org\/10.1242\/jcs.092965","journal-title":"J Cell Sci"},{"issue":"1","key":"3848_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12883-019-1362-y","volume":"19","author":"Z Liu","year":"2015","unstructured":"Liu Z, Liu H, Liu Z, Zhang J (2015) Oligodendroglial tumours: subventricular zone involvement and seizure history are associated with CIC mutation status. BMC Neurol 19(1):134. https:\/\/doi.org\/10.1186\/s12883-019-1362-y","journal-title":"BMC Neurol"},{"issue":"5","key":"3848_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2217\/cns.15.32","volume":"4","author":"DP Cahill","year":"2015","unstructured":"Cahill DP, Louis DN, Cairncross JG (2015) Molecular background of oligodendroglioma: 1p\/19q, IDH, TERT, CIC and FUBP1. CNS Oncol 4(5):287\u2013294. https:\/\/doi.org\/10.2217\/cns.15.32","journal-title":"CNS Oncol"},{"issue":"1","key":"3848_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/path.2995","volume":"226","author":"S Yip","year":"2012","unstructured":"Yip S et al (2012) Concurrent CIC mutations, IDH mutations, and 1p\/19q loss distinguish oligodendrogliomas from other cancers. J Pathol 226(1):7\u201316. https:\/\/doi.org\/10.1002\/path.2995","journal-title":"J Pathol"},{"issue":"22","key":"3848_CR27","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1158\/0008-5472.CAN-17-1018","volume":"77","author":"R Yang","year":"2017","unstructured":"Yang R et al (2017) CIC loss promotes gliomagenesis via aberrant neural stem cell proliferation and differentiation. Can Res 77(22):6097\u20136108. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1018","journal-title":"Can Res"},{"issue":"15","key":"3848_CR28","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1158\/0008-5472.CAN-18-0342","volume":"78","author":"S Weissmann","year":"2018","unstructured":"Weissmann S et al (2018) The tumor suppressor CIC directly regulates MAPK pathway genes via histone deacetylation. Can Res 78(15):4114\u20134125. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0342","journal-title":"Can Res"},{"issue":"6","key":"3848_CR29","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1080\/15384101.2018.1450029","volume":"17","author":"L Sim\u00f3n-Carrasco","year":"2018","unstructured":"Sim\u00f3n-Carrasco L, Jim\u00e9nez G, Barbacid M, Drosten M (2018) The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer. Cell Cycle 17(6):702\u2013711. https:\/\/doi.org\/10.1080\/15384101.2018.1450029","journal-title":"Cell Cycle"},{"issue":"81","key":"3848_CR30","doi-asserted-by":"publisher","first-page":"35203","DOI":"10.18632\/oncotarget.26230","volume":"9","author":"D Inoue","year":"2018","unstructured":"Inoue D, Fujino T, Kitamura T (2018) ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells. Oncotarget 9(81):35203\u201335204. https:\/\/doi.org\/10.18632\/oncotarget.26230","journal-title":"Oncotarget"},{"key":"3848_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-8722-5-12","volume":"5","author":"V Gelsi-Boyer","year":"2012","unstructured":"Gelsi-Boyer V, Brecqueville M, Devillier R, Murati A, Mozziconacci MJ, Birnbaum D (2012) Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases. J Hematol Oncol 5:12. https:\/\/doi.org\/10.1186\/1756-8722-5-12","journal-title":"J Hematol Oncol"},{"issue":"3","key":"3848_CR32","doi-asserted-by":"publisher","first-page":"e1501354","DOI":"10.1126\/sciadv.1501354","volume":"2","author":"RR Lulla","year":"2016","unstructured":"Lulla RR, Saratsis AM, Hashizume R (2016) Mutations in chromatin machinery and pediatric high-grade glioma. Sci Adv 2(3):e1501354\u2013e1501354. https:\/\/doi.org\/10.1126\/sciadv.1501354","journal-title":"Sci Adv"},{"key":"3848_CR33","doi-asserted-by":"publisher","first-page":"e1035","DOI":"10.1016\/j.wneu.2019.03.033","volume":"126","author":"A Szathmari","year":"2019","unstructured":"Szathmari A, Zerah M, Vinchon M, Dufour C, Gimbert E, Di Rocco F, Chabaud S, Conter C, Mottolese C, Frappaz D (2019) Ependymoma of the Spinal Cord in children: a retrospective French study. World Neurosurg 126:e1035\u2013e1041. https:\/\/doi.org\/10.1016\/j.wneu.2019.03.033","journal-title":"World Neurosurg"},{"issue":"3","key":"3848_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3171\/2014.9.PEDS1473","volume":"15","author":"Y Lin","year":"2015","unstructured":"Lin Y, Jea A, Melkonian SC, Lam S (2015) Treatment of pediatric grade II spinal ependymomas: a population-based study. J Neurosurg Pediatr 15(3):243\u2013249. https:\/\/doi.org\/10.3171\/2014.9.PEDS1473","journal-title":"J Neurosurg Pediatr"},{"issue":"5","key":"3848_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.tranon.2015.08.001","volume":"8","author":"JH Phi","year":"2015","unstructured":"Phi JH et al (2015) Overcoming chemoresistance of pediatric ependymoma by inhibition of STAT3 signaling. Transl Oncol 8(5):376\u2013386. https:\/\/doi.org\/10.1016\/j.tranon.2015.08.001","journal-title":"Transl Oncol"},{"key":"3848_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12967-015-0627-5","volume":"13","author":"R Mukthavaram","year":"2015","unstructured":"Mukthavaram R et al (2015) Effect of the JAK2\/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres. J Transl Med 13:269. https:\/\/doi.org\/10.1186\/s12967-015-0627-5","journal-title":"J Transl Med"},{"issue":"9","key":"3848_CR37","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1038\/s41375-019-0459-z","volume":"33","author":"M Lin","year":"2019","unstructured":"Lin M et al (2019) JAK2 p.G571S in B-cell precursor acute lymphoblastic leukemia: a synergizing germline susceptibility. Leukemia 33(9):2331\u20132335. https:\/\/doi.org\/10.1038\/s41375-019-0459-z","journal-title":"Leukemia"},{"issue":"5","key":"3848_CR38","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","volume":"164","author":"D Sturm","year":"2016","unstructured":"Sturm D, Orr BA, Toprak UH et al (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164(5):1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2016.01.015","journal-title":"Cell"},{"issue":"1","key":"3848_CR39","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s41598-018-19389-9","volume":"8","author":"A Burford","year":"2018","unstructured":"Burford A, Mackay A, Popov S et al (2018) The ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion. Sci Rep 8(1):1032. https:\/\/doi.org\/10.1038\/s41598-018-19389-9","journal-title":"Sci Rep"},{"issue":"2","key":"3848_CR40","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/nan.12593","volume":"46","author":"K Yamasaki","year":"2020","unstructured":"Yamasaki K, Nakano Y, Nobusawa S, Okuhiro Y, Fukushima H, Inoue T, Murakami C, Hirato J, Kunihiro N, Matsusaka Y, Honda-Kitahara M, Ozawa T, Shiraishi K, Kohno T, Ichimura K, Hara J (2020) Spinal cord astroblastoma with an EWSR1-BEND2 fusion classified as a high-grade neuroepithelial tumour with MN1 alteration. Neuropathol Appl Neurobiol 46(2):190\u2013193. https:\/\/doi.org\/10.1111\/nan.12593","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"3848_CR41","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1038\/s41467-019-11884-5","volume":"10","author":"KW Pajtler","year":"2019","unstructured":"Pajtler KW et al (2019) YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis. Nat Commun 10(1):3914. https:\/\/doi.org\/10.1038\/s41467-019-11884-5","journal-title":"Nat Commun"},{"issue":"2","key":"3848_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/bpa.12659","volume":"29","author":"F Andreiuolo","year":"2019","unstructured":"Andreiuolo F, Varlet P, Tauzi\u00e8de-Espariat A et al (2019) Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features. Brain Pathol 29(2):205\u2013216. https:\/\/doi.org\/10.1111\/bpa.12659","journal-title":"Brain Pathol"},{"key":"3848_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-021-02074-2.10.1007\/s00109-021-02074-2","author":"GR de Sousa","year":"2021","unstructured":"de Sousa GR, Lira RCP, de Almeida MT et al (2021) A coordinated approach for the assessment of molecular subgroups in pediatric ependymomas using low-cost methods. J Mol Med. https:\/\/doi.org\/10.1007\/s00109-021-02074-2.10.1007\/s00109-021-02074-2","journal-title":"J Mol Med"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03848-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-021-03848-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03848-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T05:12:27Z","timestamp":1635138747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-021-03848-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,10,30]]}},"alternative-id":["3848"],"URL":"https:\/\/doi.org\/10.1007\/s11060-021-03848-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2021,9,27]]},"assertion":[{"value":"17 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Research Committee (Committee for Ethics in Research \u2013 Federal University of Sao Paulo No. 0915\/2019). This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Samples from each primary tumor were collected after informed consent was signed by patients\/guardians. The biological material is acquired via a Biobank of the Pediatric Oncology Institute-GRAACC\/UNIFESP (National Commission of Ethics in Research - CONEP B-053).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}